ALEXANDER CHASE: Open Payments
NPI 1740684653 · REHOBOTH BEACH, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 5 payments from 5 companies in 2025. Trend: 2023 $188 · 2024 $303 · 2025 $195
Education: $121Food & beverage: $73
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $78 |
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Celgene Corporation | 1 | $29 |
| ABBVIE INC. | 1 | $16 |
Products named: DARZALEX, ENHERTU, Fabhalta, REBLOZYL, IMBRUVICA.
Industry payments across DE — which companies pay providers there.
